跳至主要内容
临床试验/NCT03292965
NCT03292965已完成不适用

Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery: Comparison of Neostigmine and Sugammadex

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年9月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
the incidence of postoperative residual curarization

研究概览

简要总结

Compare the reversal effect of neostigmine and sugammadex using quantitative neuromuscular monitoring

详细描述

At the end of surgery, decide the dosage of reversal referring to quantitative neuromuscular monitoring value (TOF). After the administration of reversal, the anesthesiologist who are going to manage the participant should not check the quantitative neuromuscular monitoring and determine the timing of extubation only with his (or her) judgement. After entering post-anaesthesia care unit (PACU) measure the TOF value and check the incidence of TOF ratio > 0.9 between the neostigmine group and sugammadex group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients aged over 18 years, planned to undergoing elective laparoscopic surgery under general anesthesia

排除标准

  • Obesity BMI over 30 kg/m2
  • Impairment of renal or/and liver function
  • Allergy to rocuronium, sugammadex
  • (Familial) history of malignant hyperthermia
  • Taking medicines which is affecting neuromuscular function

研究组 & 干预措施

Neostigmine

Active Comparator

At the end of surgery, administrating neostigmine to participants according to the protocol below:

when train-of-four (TOF) 2-3, administrating neostigmine 50mcg/kg when TOF 4 with fade, administrating neostigmine 40mcg/kg when TOF 4 without fade, administrating neostigmine 20mcg/kg

干预措施: Neostigmine (Drug)

Sugammadex

Active Comparator

At the end of surgery, administrating sugammadex to participants according to the protocol below:

when TOF=0 and post-tetanic count (PTC)=1 or more, administrating sugammadex 4mg/kg when TOF=1 or more, administrating sugammadex 2mg/kg when TOF 4 without fade, administrating neostigmine 20mcg/kg

干预措施: Sugammadex (Drug)

结局指标

主要结局

the incidence of postoperative residual curarization

时间窗: Immediately after entering PACU

definition of postoperative residual curarization: TOF ration is 0.9 or over 0.9

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

LEE YEA JI

clinical professor of department of anesthesiology and pain medicine

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验

Monitoring of Postoperative Residual Neuromuscular... | 临床试验